Inventor · disambiguated record
Varda Shoshan-Barmatz
Also filed as: SHOSHAN-BARMATZ VARDA
18 granted patents·13 pending applications·27 citations·filing 2006–2024
90Inventor score
Files withNAT INST BIOTECHNOLOGY NEGEV LTD13B G NEGEV TECHNOLOGIES AND APPLICATIONS LTD AT BEN GURION UNIV6SHOSHAN-BARMATZ VARDA6NAT INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD2B G NEGEV TECH AND APPLICATIONS LTD AT BEN-GURION UNIV1
Top patents by PatentIndex Score
31 records- 0184US10508091B2Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC oligomerization, apoptosis and mitochondria dysfunctionNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2016·Granted Dec 17, 2019·3 cites·7 claims
- 0283US10434099B2Methods for treating central nervous system disorders using VDAC inhibitorsNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2017·Granted Oct 8, 2019·2 cites·5 claims
- 0382US8119601B2Voltage dependent anion channel (VDAC1) compositions and methods of use thereof for regulating apoptosisSHOSHAN-BARMATZ VARDA·Filed 2006·Granted Feb 21, 2012·7 cites·12 claims
- 0481US11472777B2Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC oligomerization, apoptosis and mitochondria dysfunctionNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2020·Granted Oct 18, 2022·1 cites·8 claims
- 0579US10385104B2Analogues of VDAC1-derived peptidesB G NEGEV TECHNOLOGIES AND APPLICATIONS LTD AT BEN GURION UNIV·Filed 2018·Granted Aug 20, 2019·1 cites·8 claims
- 0678US10787423B2Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC oligomerization, apoptosis and mitochondria dysfunctionNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2019·Granted Sep 29, 2020·1 cites·17 claims
- 0778US2025101433A1Means and methods for reducing tumorigenicity of cancer stem cellsB G NEGEV TECHNOLOGIES AND APPLICATIONS LTD AT BEN GURION UNIV·Filed 2024·Application pending·0 cites
- 0877US8648045B2VDAC1 compositions and methods of use thereof for regulating apoptosisSHOSHAN-BARMATZ VARDA·Filed 2012·Granted Feb 11, 2014·7 cites·11 claims
- 0976US11408887B2Biomarkers for diagnosis of lung cancerNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2018·Granted Aug 9, 2022·1 cites·4 claims
- 1071US2022056456A1Means and methods for reducing tumorigenicity of cancer stem cellsB G NEGEV TECHNOLOGIES AND APPLICATIONS LTD AT BEN GURION UNIV·Filed 2021·Application pending·0 cites
- 1170US9758559B2Short peptides derived from VDAC1, compositions and methods of use thereofB G NEGEV TECH AND APPLICATIONS LTD AT BEN-GURION UNIV·Filed 2014·Granted Sep 12, 2017·1 cites·8 claims
- 1270US2022170114A1Biomarkers of chronic lymphocytic leukemia and use thereofNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2022·Application pending·0 cites
- 1369US8093369B2Compositions for silencing the expression of VDAC1 and uses thereofSHOSHAN-BARMATZ VARDA·Filed 2006·Granted Jan 10, 2012·1 cites·4 claims
- 1469US2023055614A1Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting vdac oligomerization, apoptosis and mitochondria dysfunctionNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2022·Application pending·0 cites
- 1568US11976280B2SMAC/Diablo inhibitors useful for treating cancerNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2022·Granted May 7, 2024·0 cites·14 claims
- 1668US11634465B2Analogues of VDAC1-derived peptidesB G NEGEV TECHNOLOGIES AND APPLICATIONS LTD AT BEN GURION UNIV·Filed 2020·Granted Apr 25, 2023·0 cites·9 claims
- 1768US10829530B2Analogues of VDAC1-derived peptidesB G NEGEV TECHNOLOGIES AND APPLICATIONS LTD AT BEN GURION UNIV·Filed 2019·Granted Nov 10, 2020·0 cites·8 claims
- 1865US8440788B2N-terminal VDAC variants and uses thereofSHOSHAN-BARMATZ VARDA·Filed 2007·Granted May 14, 2013·2 cites·14 claims
- 1964US10946013B2Methods for treating central nervous system disorders using vdac inhibitorsNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2019·Granted Mar 16, 2021·0 cites·20 claims
- 2058US11286533B2Biomarkers of chronic lymphocytic leukemia and use thereofNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2016·Granted Mar 29, 2022·0 cites·10 claims
- 2158US2025051409A1MODULATORS OF PHOSPHATIDYLSERlNE DECARBOXYLASE AND USE THEREOFNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2022·Application pending·0 cites
- 2256US11174484B2Means and methods for reducing tumorigenicity of cancer stem cellsB G NEGEV TECHNOLOGIES AND APPLICATIONS LTD AT BEN GURION UNIV·Filed 2016·Granted Nov 16, 2021·0 cites·3 claims
- 2353US2023066049A1Peptides useful in preservation and/or restoration of functional pancreatic islets and in treating diabetesNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2021·Application pending·0 cites
- 2447US2010092995A1Fluorescent ruthenium compounds for detecting calcium binding proteinsSHOSHAN-BARMATZ VARDA·Filed 2007·Application pending·0 cites
- 2546US11555192B2SMAC/Diablo inhibitors useful for treating cancerNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2018·Granted Jan 17, 2023·0 cites·8 claims
- 2646US2021395752A1Vdac1 silencing molecules and use thereofNAT INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD·Filed 2019·Application pending·0 cites
- 2745US2021130291A1Methods for treating diabetes using vdac1 inhibitorsSALEHI ALBERT·Filed 2017·Application pending·0 cites
- 2844US2022023381A1Vdac inhibitors for treating autoimmune diseasesNAT INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD·Filed 2019·Application pending·0 cites
- 2943US2014186837A1Methods For Diagnosing CancerNAT INST FOR BIOTECHNOLOGY IN THE NEGEV LTD·Filed 2014·Application pending·0 cites
- 3041US2022202716A1Empty porous particles for use in treatment, prevention and/or postponement of degeneration of neurodegenerative diseases, neurons and gliaNANOLOGICA AB·Filed 2020·Application pending·0 cites
- 3138US2012164730A1Compositions for silencing the expression of vdac1 and uses thereofSHOSHAN-BARMATZ VARDA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Varda Shoshan-Barmatz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →